Novel drug, testing methods show promise for speeding new treatments for breast cancer

SAN ANTONIO – An experimental drug is showing promise against a hard-to-treat form of breast cancer. It’s the first big result from a novel way to test drugs that quickly separates winners from duds.

Doctors say the results on veliparib (veh-LIP-uh-rib) suggest it deserves further testing in a big study aimed at winning federal approval.

The drug was tested on small groups of women who were quickly given surgery to see its effect on their tumors. Each person’s results helped inform how the next women in the study were treated.

Researchers say this learn-as-you-go approach should get promising treatments to market faster and at a lower cost.

The study was discussed Friday at a conference in San Antonio.

News from © The Associated Press, . All rights reserved.
This material may not be published, broadcast, rewritten or redistributed.

Join the Conversation!

Want to share your thoughts, add context, or connect with others in your community? Create a free account to comment on stories, ask questions, and join meaningful discussions on our new site.

Leave a Reply

The Associated Press

The Associated Press

The Associated Press is an independent global news organization dedicated to factual reporting. Founded in 1846, AP today remains the most trusted source of fast, accurate, unbiased news in all formats and the essential provider of the technology and services vital to the news business. More than half the world’s population sees AP journalism every day.